Home›Companies›Biotech & Pharma›Corami Biotech

Corami Biotech Inc.

Corami develops a heart-targeted drug delivery system for companies developing cardiovascular therapies.

Updated Nov 10, 2026·Latest SEC filing Apr 22, 2026·Suggest an edit

About Corami Biotech

Corami Biotech is a private company based in Memphis, Tennessee, incorporated in 2024 in Delaware. It has reported $230,000 raised in three offerings on Form D since October 2024. Its chief executive is Esra Roan.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 4, 2026Apr 22, 2026$230,000of $1.0M target3$76,667OptionsRule 506(b)Form D ↗
Not yetJan 17, 2025$0of $100K target0—DebtRule 506(b)Form D ↗
Oct 24, 2024Oct 28, 2024$0of $110K target2$0OptionsRule 506(b)Form D ↗
Total, three offerings$230,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Corami Biotech's Form D filed Apr 22, 2026.

Esra Roan
Esra Roan
Chief Executive Officer and director
Also an executive officer and director at SOMAVAC Medical Solutions.
Brian Walsh
Brian Walsh
Medical Technology Executive and director
Rifat Pamukcu
Rifat Pamukcu
Chairperson of the Board
Also a director at BobcatBio.

Sources

  1. SECCorami Biotech Inc. filing history
  2. CompanyCorami Biotech team